News Image

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Humacyte, Inc. of Class Action Lawsuit and Upcoming Deadlines - HUMA

Provided By PR Newswire

Last update: Jan 8, 2025

NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Humacyte, Inc. ("Humacyte" or the "Company") (NASDAQ: HUMA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Read more at prnewswire.com

HUMACYTE INC

NASDAQ:HUMA (3/3/2025, 8:00:02 PM)

Premarket: 2.95 -0.11 (-3.59%)

3.06

-0.34 (-10%)



Find more stocks in the Stock Screener

Follow ChartMill for more